Collaboration will combine AbbVie’s oncology expertise and Xilio’s proprietary tumor-activation technology to develop novel immunotherapies, ...
AbbVie (ABBV) and Xilio Therapeutics (XLO) announced a collaboration and option-to-license agreement to develop novel tumor-activated, ...
According to Reuters, the grocery retailer notified Express Scripts in September 2022 of its plan to terminate the pharmacy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results